CureVac Down Over 12%, on Pace for Largest Percent Decrease in Almost Two Years -- Data Talk

Dow Jones
4 hours ago

CureVac N.V. $(CVAC)$ is currently at $4.22, down $0.61 or 12.55%

 

--Would be lowest close since June 11, 2025, when it closed at $4.07

--On pace for largest percent decrease since Dec. 19, 2023, when it fell 29.55%

--Currently down six of the past seven days

--Currently down four consecutive days; down 17.68% over this period

--Longest losing streak since Nov. 21, 2025, when it fell for four straight trading days

--Worst four day stretch since the four days ending June 20, 2024, when it fell 18.5%

--Down 23.22% month-to-date

--Up 23.61% year-to-date; on pace for best year on record (Based on available data back to Aug. 14, 2020)

--Down 96.91% from its all-time closing high of $136.27 on Dec. 9, 2020

--Up 53.27% from 52 weeks ago (Dec. 18, 2024), when it closed at $2.75

--Down 24.73% from its 52-week closing high of $5.60 on June 12, 2025

--Up 62.74% from its 52-week closing low of $2.59 on April 4, 2025

--Traded as low as $4.16; lowest intraday level since June 11, 2025, when it hit $4.07

--Down 13.59% at today's intraday low; largest intraday percent decrease since Jan. 8, 2025, when it fell as much as 17.31%

 

All data as of 1:54:26 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 17, 2025 13:57 ET (18:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10